PIERRE FABRE MEDICAMENT;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS);UNIVERSITE DE STRASBOURG
发明人:
申请号：
EP16305672.4
公开号：
EP3266784A1
申请日:
2016.06.08
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention relates to a compound of following formula (I):or a pharmaceutically acceptable salt and/or solvate thereof,notably for use thereof as a drug, notably in the treatment of cancer, or as a PRMT inhibitor.The present invention relates also to a pharmaceutical composition containing such a compound and to a method for the preparation of such a compound.
